Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Delirium, Cognitive Impairment
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sickle Cell Disease, Cognitive Impairment, Adolescent Behavior, Self Efficacy, Health-Related Behavior, Coping Skills
Interventions: CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 10 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Mild Traumatic Brain Injury
Interventions: Passive neurosensory reintegration training (PNRT); Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Posttraumatic Stress Disorder, Cardiovascular Diseases, Autonomic Dysfunction, Vascular Stiffness, Nightmare, Endothelial Dysfunction
Interventions: NightWare, Sham NightWare; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 22 Years to 99 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 55 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Anthracycline Related Cardiotoxicity in Breast Cancer
Interventions: sulforaphane, Placebo Oral Tablet; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease, Meibomitis, Meibomian Gland Dysfunction, Dry Eye
Interventions: Maskin Probe; Device
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dementia (Diagnosis), Mild Cognitive Impairment, Alzheimer's Disease Dementia, Alzheimer's Disease
Interventions: CYOA booklet; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cognitive Disorders
Interventions: SUVN-G3031, Placebo; Drug
Lead sponsor: Suven Life Sciences Limited; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Cognitive Decline, Dementia, Alzheimer Disease, Vascular Dementia
Interventions: MIND Diet, Mild Weight Loss; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 65 Years to 84 Years
Enrollment: 604 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: Sexual Dysfunction, Depression
Interventions: sildenafil; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Peripheral Vascular Disease, Lipid Disorder, Endothelial Dysfunction
Interventions: High Saturated Fat; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 40 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Wauwatosa, Wisconsin

Conditions: Mild Cognitive Impairment
Interventions: Walking Intervention, Cognitive Training Intervention, Combined Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 60 Years to 80 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Skin Laxity, Meibomian Gland Dysfunction
Interventions: THERMIeyes® 20 RF System; Device
Lead sponsor: Ophthalmic Consultants of Long Island; Other
Eligibility: 40 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Lynbrook, New York

Conditions: Bladder Dysfunction, Overactive Bladder, BPH With Urinary Obstruction
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,023 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Anxiety Disorder, Cervical Cancer, Endometrial Cancer, Female Reproductive Cancer, Gestational Trophoblastic Tumor, Ovarian Epithelial Cancer, Ovarian Germ Cell Tumor, Sexual Dysfunction, Uterine Sarcoma, Vaginal Cancer, Vulvar Cancer
Interventions: informational intervention, counseling intervention, questionnaire administration; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Symptomatic Menopause, Cognitive Impairments
Interventions: Lisdexamfetamine, Placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 45 Years to 60 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bronchopulmonary Dysplasia
Interventions: Infasurf surfactant (ONY, Inc.), Sham (No Treatment); Drug
Lead sponsor: Roberta Ballard; Other
Eligibility: 7 Days to 14 Days
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 21
States / cities: Little Rock, Arkansas • Berkeley, California • Oakland, California + 15 more

Conditions: Alzheimer Disease, Alzheimer's Disease (Incl Subtypes), Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease, Mild Cognitive Impairment, Normal Cognition
Interventions: Not listed
Lead sponsor: Novoic Limited; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Santa Ana, California

Conditions: Osteoarthritis
Interventions: Resistance exercise training; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 60 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Obesity, Prehypertension, Hypertension
Interventions: Clonidine, Hydrochlorothiazide, Placebo; Drug
Lead sponsor: Gary L. Pierce; Other
Eligibility: 18 Years to 79 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Premature Ejaculation
Interventions: Placebo, PSD502; Drug
Lead sponsor: Plethora Solutions Ltd; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 21
States / cities: Birmingham, Alabama • Mobile, Alabama • Sherman Oaks, California + 18 more

Conditions: Irritable Bowel Syndrome
Interventions: DNK333; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 29
States / cities: Anniston, Alabama • Huntsville, Alabama • Northport, Alabama + 26 more

Conditions: Post Acute COVID 19 Syndrome, Memory Impairment, Memory Dysfunction, Cognitive Dysfunction
Interventions: HOBSCOTCH-PACS; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 20 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Search by objective public record fields.

Cholinesterase Activity and DeliriUm During Critical Illness Study

Cognitive Remediation Intervention to Prepare for Transition of Care

Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury

NightWare and Cardiovascular Health in Adults With PTSD

MCI Speech in Noise

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Choose Myself (Before) Losing Myself

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects

MIND Diet Intervention and Cognitive Decline

Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women

Effect of Plasma Ceramides on Peripheral Vascular Function

Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI

Evaluation of Ocular Surface Changes Following RF Electrocoagulation Treatment of the Periorbital Region

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

Attention & Memory Impairments in Menopausal Women

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension

Chronic Muscle Disuse in the Elderly

Vascular Dysfunction in Human Obesity Hypertension

PSD502 in Subjects With Premature Ejaculation

Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)